Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.71 |
| ▸ | TTPA | P49638 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | AKT1 | P31749 | 4/20 | 0.64 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.64 |
| ▸ | PHLPP1 | O60346 | 1/20 | 0.64 |
| ▸ | ILK | Q13418 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.60 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.59 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17874902 | 1.00 | LMNA (0.71) | LMNAMAPTMEN1KMT2AGSTP1 | |
| SCHEMBL2695150 | 1.00 | LMNA (0.71) | LMNAMAPTMEN1KMT2AGSTP1 | |
| SCHEMBL39202 | 1.00 | LMNA (0.71) | LMNAMAPTMEN1KMT2AGSTP1 | |
| SCHEMBL14695837 | 1.00 | LMNA (0.71) | LMNAMAPTMEN1KMT2AGSTP1 | |
| Alcohol SCHEMBL28691903 | 0.97 | LMNA (0.67) | LMNAMAPTMEN1KMT2AGSTP1 | |
| Hydroquinone SCHEMBL14164332 | 0.96 | LMNA (0.66) | LMNAMAPTMEN1KMT2AGSTP1 | |
| SCHEMBL17011751 | 0.96 | LMNA (0.64) | LMNAMAPTMEN1KMT2AGSTP1 | |
| Phosphoric Acid SCHEMBL20917308 | 0.95 | GSTO1 (0.65) | LMNAMAPTMEN1KMT2AGSTP1 | |
| Acetic Acid SCHEMBL708028 | 0.95 | LMNA (0.64) | LMNAMAPTMEN1KMT2AGSTP1 | |
| Phosphoric Acid SCHEMBL8652705 | 0.95 | GSTO1 (0.65) | LMNAMAPTMEN1KMT2AGSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118716499-A | Preparation method of water-soluble vitamin E | 浙江威仕生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2025132513-A1 | LOW-ENERGY ELECTRON IRRADIATION-INACTIVATED MOLLICUTES | INTERVET INTERNATIONAL B.V. (NL) | 2025-06-26 | — | — | WO | disclosed |
| US-20250057934-A1 | STABLE EMULSIONS OF ANTIGENS | INTERVET INC. (US) | 2025-02-20 | — | — | US | disclosed |
| CN-119215198-A | Preparation method of fat-soluble vitamin E powder | 浙江工业大学 | 2024-12-31 | — | — | CN | disclosed |
| CN-114842949-B | Human food intake evaluation system and method based on regression analysis | 上海五里多科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-20240368503-A1 | Core-Shell Microcapsule with a Polyamine-Based Thermosetting Shell | GIVAUDAN SA (CH) | 2024-11-07 | — | — | US | disclosed |
| EP-4452315-A1 | STABLE EMULSIONS OF ANTIGENS | Intervet International B.V. (NL) | 2024-10-30 | — | — | EP | disclosed |
| CN-118716499-A | Preparation method of water-soluble vitamin E | 浙江威仕生物科技有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-118716499-A | Preparation method of water-soluble vitamin E | 浙江威仕生物科技有限公司 | 2024-10-01 | — | — | CN | disclosed |
| WO-2010051277-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | EDISON PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2010-04-29 | — | — | US | disclosed |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | PTC THERAPEUTICS, INC. | 2010-04-29 | — | — | US | disclosed |
| US-7060199-B2 | Biodegradable functional fluid for mechanical drives | TEA GMBH TECHNNOLOGIEZENTRUM, EMISSIONSFREIE ANTRIEBE (DE) | 2006-06-13 | — | — | US | disclosed |
| US-6913707-B2 | Biodegradable functional fluid for mechanic drives | TEA GMBH (DE) | 2005-07-05 | — | — | US | disclosed |
| US-20050143264-A1 | Biodegradable functional fluid for mechanical drives | TEA GMBH TECHNOLOGIEZENTRUM, EMISSIONSFREIE ANTRIEBE | 2005-06-30 | — | — | US | disclosed |
| US-20040094743-A1 | Biodegradable functional fluid for mechanic drives | TEA GMBH TECHNOLOGIEZENTRUM, EMISSIONSFREIE ANTRIEBE (DE) | 2004-05-20 | — | — | US | disclosed |
| EP-1320576-A2 | BIODEGRADABLE FUNCTIONAL FLUID FOR MECHANIC DRIVES | Tea GmbH (DE) | 2003-06-25 | — | — | EP | disclosed |
| WO-2002024841-A2 | BIODEGRADABLE FUNCTIONAL LIQUID FOR MECHANIC DRIVES | TEA GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057934-A1 | STABLE EMULSIONS OF ANTIGENS | CETP, PIGS, TTPA | LMNA 1823/4885MAPT 2244/4885MEN1 4649/4885 |
| US-20240368503-A1 | Core-Shell Microcapsule with a Polyamine-Based Thermosetting Shell | SRM, SMS, PNMT | LMNA 3602/4885MAPT 69/4885MEN1 358/4885 |
| US-20100105930-A1 | PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES | TTPA, LCAT, PCTP | LMNA 2953/4885MAPT 2318/4885MEN1 3263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.